Transgene Biotek has informed that in terms of Company's Code of Internal Procedure and Conduct for Regulating, Monitoring and Reporting of trading by Designated persons, pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, read with the clarification issued by BSE vide Circular No. LIST/COMP/01/2019-20 dated 02nd April 2019, the Trading window for dealing in the securities of the Company for all Designated Persons and immediate relatives of Designated Person, will remain closed from immediate effect till expiry of 48 hours after the financial results for the quarter and year ended 31 st March 2020 become generally available information. The date of meeting of the Board of Directors to approve the Audited financials results of the Company for the quarter and year ended March 31, 2020 will be informed in due course.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Syngene Internation. | 435.70 |
| Indegene | 486.80 |
| CMS Info Systems | 318.00 |
| JITF Infralogistics | 338.00 |
| Sagility | 42.95 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: